Intrinsic Value of S&P & Nasdaq Contact Us

Valneva SE VALN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • FR • USD

SharesGrow Score
44/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.33
+201%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Valneva SE (VALN) has a negative trailing P/E of -3.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 8.8 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -25.98%, forward earnings yield 11.38%. PEG 0.24 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.24); analyst target implies upside (+201%).
  • Forward P/E 8.8 — analysts expect a return to profitability with estimated EPS of $0.69 for FY2027.
  • PEG Ratio 0.24 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -25.98% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 11.38% as earnings recover.
  • Analyst consensus target $18.33 (+201% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 44/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
44/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — VALN

Valuation Multiples
P/E (TTM)-3.8
Forward P/E8.8
PEG Ratio0.24
Forward PEG0.24
P/B Ratio4.18
P/S Ratio2.52
EV/EBITDA-7.9
Per Share Data
EPS (TTM)$-0.66
Forward EPS (Est.)$0.69
Book Value / Share$0.61
Revenue / Share$1.01
FCF / Share$-0.43
Yields & Fair Value
Earnings Yield-25.98%
Forward Earnings Yield11.38%
Dividend Yield0.00%
Analyst Target$18.33 (+201%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -19.0 -0.14 9.36 9.95 -
2017 -73.3 0.95 9.09 8.00 -
2018 284.1 -2.24 6.48 8.20 -
2019 -619.4 4.22 7.99 8.56 -
2020 -15.2 0.00 12.67 8.89 -
2021 -32.5 -5.76 13.97 6.85 -
2022 -4.8 -0.07 3.12 1.90 -
2023 -6.4 0.16 5.08 4.24 -
2024 -24.2 0.27 1.64 1.75 -
2025 -5.5 -0.01 5.95 3.61 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-1.32 $94.06M $-49.18M -52.3%
2017 $-0.30 $105.29M $-11.48M -10.9%
2018 $0.08 $113.04M $3.26M 2.9%
2019 $-0.04 $126.2M $-1.74M -1.4%
2020 $-1.42 $110.32M $-64.39M -58.4%
2021 $-1.50 $348.09M $-73.43M -21.1%
2022 $-2.48 $361.3M $-143.28M -39.7%
2023 $-1.46 $153.71M $-101.43M -66%
2024 $-0.17 $169.58M $-12.25M -7.2%
2025 $-1.32 $174.66M $-115.19M -66%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.82 $-0.91 – $-0.75 $166.55M $155.93M – $180.84M 1
2027 $0.70 $0.64 – $0.78 $319.56M $299.19M – $346.98M 1
2028 $0.30 $0.27 – $0.33 $271.03M $253.75M – $294.28M 1
2029 $0.67 $0.61 – $0.74 $325.39M $304.65M – $353.32M 1
2030 $1.78 $1.63 – $1.98 $435.41M $407.65M – $472.77M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message